Clinical Trials Update: Oct. 19, 2006
Recurrent Pregnancy Loss Glaucoma Alzheimer's Disease
(HealthDay News) -- Here are the latest clinical trials, courtesy of Thomson CenterWatch:
Recurrent Pregnancy Loss
This study seeks female volunteers with a history of pregnancy loss. Participants must have experienced one of the following: recurrent pregnancy loss (defined as two or more pregnancy losses at any gestation age), fetal demise (10 weeks gestation or greater), or recurrent IVF failure (at least two previous embryo transfers, each of which resulted in failure of implantation or a miscarriage at eight or fewer weeks of gestation).
The research site is in Chicago, Ill.
This study will research glaucoma and ocular hypertension. There will be four office visits over a three-month period. Participants will receive study medication and study-related eye exams at no cost and may be compensated for time and travel. Candidates must be at least 18 years of age and must not have had eye surgery in the prior three months.
The research site is in Philadelphia, Penn.
This study will evaluate people with mild-to-moderate symptoms of Alzheimer's disease. Participants must be taking a stable dose of either Aricept, Reminyl or Excelon for the prior 12 weeks. The study will include 21 visits, and diagnostic and laboratory evaluations will be done at no cost. Participants also may be reimbursed for time and travel.
The research site is in Richmond, Va.
Copyright 2006 Thomson CenterWatch. All rights reserved.